Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Alimentary Health (AH), an Ireland-based developer of probiotic and pharmabiotic treatments for gastro-intestinal disorders, has signed a development agreement with the Netherlands-based pharma products developer Norgine.
Subscribe to our email newsletter
Under the deal, both the firms will jointly evaluate certain AH proprietary probiotic technology to develop as a treatment or management of gastrointestinal (GI) conditions.
Following the completion of the programme, Norgine will have an option to negotiate a license to commercialize the technology.
The tie up allows AH to obtain upfront payment from Norgine and is eligible to get additional payments upon the completion of certain development milestones.
AH CEO Barry Kiely said this partnership is further validation of AH’s technology and recognition of their position at the forefront of research into probiotic technology.